News

Home / News

To announce the release of non-competition restrictions for managerial officer

2024.5.6

1.Date of the board of directors resolution:2024/05/06

2.Name and title of the managerial officer with permission to engage in competitive conduct:Sze-Yuan Yang;General Manager

3.Items of competitive conduct in which the officer is permitted to engage:Chairman of TOP PHARM. MEDICALWARE COMPANY LIMITED;
Chairman of TOP Biological Technology Company Limited

4.Period of permission to engage in the competitive conduct:During the term of being a managerial officer of the Company.

5.Circumstances of the resolution (please describe the results of voting in accordance with Article 32 of the Company Act):All present directors unanimously approved it.

6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the managerial officer (if it is not the operator of a mainland China enterprise, please enter“N/A”below):NA.

7.Company name of the mainland China enterprise and the officer’s position in the enterprise:NA.

8.Address of the mainland China enterprise:NA.

9.Operations of the mainland China enterprise:NA.

10.Impact on the company’s finance and business:None.

11.If the managerial officer or director has invested in the mainland China enterprise, the monetary amount of the investment and the officer or director’s shareholding ratio:None.

12.Any other matters that need to be specified:None.